National Guideline Clearinghouse | Guideline Synthesis: Pharmacologic Interventions for Breast Cancer Risk Reduction in Women

National Guideline Clearinghouse | Guideline Synthesis: Pharmacologic Interventions for Breast Cancer Risk Reduction in Women



American Society of Clinical Oncology and

U.S. Preventive Services Task Force

Guideline Synthesis

• Pharmacologic Interventions for Breast Cancer Risk Reduction in Women New: Includes recommendations from ASCO and USPSTF.

Pharmacologic Interventions for Breast Cancer Risk Reduction in Women

Guidelines Being Compared:

1. American Society of Clinical Oncology (ASCO). Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10;31(23):2942-62. [65 references]
2. U.S. Preventive Services Task Force (USPSTF). Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013 Nov 19;159(10):698-708. [50 references]